Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) EVP Steve Weinrauch sold 11,916 shares of the firm’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $53.00, for a total value of $631,548.00. Following the completion of the sale, the executive vice president now directly owns 48,978 shares in the company, valued at approximately $2,595,834. This represents a 19.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Trupanion Trading Up 1.8 %
TRUP opened at $53.60 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company’s 50 day moving average price is $49.05 and its two-hundred day moving average price is $39.26. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of -167.50 and a beta of 1.69.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. As a group, research analysts predict that Trupanion, Inc. will post -0.23 earnings per share for the current year.
Institutional Investors Weigh In On Trupanion
Analysts Set New Price Targets
Several analysts recently weighed in on the company. Northland Securities raised their price objective on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Stifel Nicolaus raised their price target on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Bank of America lifted their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Finally, Piper Sandler boosted their target price on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $44.67.
View Our Latest Stock Report on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Learn Technical Analysis Skills to Master the Stock Market
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 11/18 – 11/22
- Which Wall Street Analysts are the Most Accurate?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.